‌

US Patent 7566450 Humanized anti-CCR2 antibodies and methods of use therefor

Patent 7566450 was granted and assigned to Millennium Pharmaceuticals on July, 2009 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 15 Sep, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 15 Sep, 2023
Edits made to:
Article (+472 characters)
Article

Patent abstract

The present invention relates to a humanized antibody or functional fragment thereof which binds to a mammalian (e.g., human) CC-chemokine receptor 2 (CCR2) or a portion of the receptor and blocks binding of a ligand to the receptor. The invention further relates to a method of inhibiting the interaction of a cell bearing mammalian CCR2 with a ligand thereof, and to use of the antibodies and fragments in therapeutic, prophylactic and diagnostic methods.

Edits on 14 Jul, 2023
"Remove leading 0 from patent number"
Golden AI profile picture
Golden AI
edited on 14 Jul, 2023
Edits made to:
Infobox (+1/-1 properties)
‌

US Patent 07566450 Humanized anti-CCR2 antibodies and methods of use therefor US Patent 7566450 Humanized anti-CCR2 antibodies and methods of use therefor

Infobox
Patent Number
0756645012
Patent Number
756645012
Edits on 25 May, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI profile picture
Golden AI
edited on 25 May, 2023
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=0756645012
Edits on 27 Mar, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 27 Mar, 2023
Infobox
Is a
Patent
Patent
1
Current Assignee
Millennium Pharmaceuticals
Millennium Pharmaceuticals
1
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
1
Patent Number
075664501
Date of Patent
July 28, 2009
1
Patent Application Number
119247941
Date Filed
October 26, 2007
1
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=075664501
Patent Primary Examiner
‌
Larry R. Helms
1
Edits on 24 Sep, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 24 Sep, 2022
Infobox
Is a
Patent
Patent
1
Current Assignee
Millennium Pharmaceuticals
Millennium Pharmaceuticals
1
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
1
Patent Number
075664501
Date of Patent
July 28, 2009
1
Patent Application Number
119247941
Date Filed
October 26, 2007
1
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=075664501
Patent Primary Examiner
‌
Larry R. Helms
1
Edits on 18 Jun, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 18 Jun, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
https://pdfpiw.uspto.gov/.piw?Docid=07566450
Edits on 2 Dec, 2021
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 2 Dec, 2021
Edits made to:
Infobox (+8 properties)
‌

 US Patent 07566450 Humanized anti-CCR2 antibodies and methods of use therefor

Infobox
Is a
Patent
Patent
Current assignee
Millennium Pharmaceuticals
Millennium Pharmaceuticals
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
07566450
Date of patent
July 28, 2009
Patent application number
11924794
Date Filed
October 26, 2007
Patent primary examiner
‌
Larry R. Helms

Find more entities like US Patent 7566450 Humanized anti-CCR2 antibodies and methods of use therefor

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.